- Home
- Publications
- Publication Search
- Publication Details
Title
Nuclear NHERF1 expression as a prognostic marker in breast cancer
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 4, Issue 11, Pages e904-e904
Publisher
Springer Nature
Online
2013-11-07
DOI
10.1038/cddis.2013.439
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- NHERF1/EBP50 Is a New Marker in Colorectal Cancer
- (2015) Yuho Hayashi et al. NEOPLASIA
- Peritumoral vascular invasion and NHERF1 expression define an immunophenotype of grade 2 invasive breast cancer associated with poor prognosis
- (2012) Andrea Malfettone et al. BMC CANCER
- The prognostic value of MARCKS-like 1 in lymph node-negative breast cancer
- (2012) Kristin Jonsdottir et al. BREAST CANCER RESEARCH AND TREATMENT
- Overexpression of nuclear NHERF1 in advanced colorectal cancer: Association with hypoxic microenvironment and tumor invasive phenotype
- (2012) Andrea Malfettone et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Breast cancer intratumor genetic heterogeneity: causes and implications
- (2012) Charlotte KY Ng et al. Expert Review of Anticancer Therapy
- Cytoplasmic Skp2 Expression Is Associated with p-Akt1 and Predicts Poor Prognosis in Human Breast Carcinomas
- (2012) Jing Liu et al. PLoS One
- Na+/H+ exchanger regulatory factor 1 expression levels in blood and tissue predict breast tumour clinical behaviour
- (2011) Antonia Bellizzi et al. HISTOPATHOLOGY
- Human epidermal growth factor receptor 2, Na+/H+ exchanger regulatory factor 1, and breast cancer susceptibility gene-1 as new biomarkers for familial breast cancers
- (2011) Annita Mangia et al. HUMAN PATHOLOGY
- Homogeneous Datasets of Triple Negative Breast Cancers Enable the Identification of Novel Prognostic and Predictive Signatures
- (2011) Thomas Karn et al. PLoS One
- Randomized phase III trial of adjuvant epirubicin followed by cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) versus CMF followed by epirubicin in patients with node-negative or 1–3 node-positive rapidly proliferating breast cancer
- (2010) Dino Amadori et al. BREAST CANCER RESEARCH AND TREATMENT
- NHERF1/EBP50 in Breast Cancer: Clinical Perspectives
- (2010) Antonia Bellizzi et al. Breast Care
- Ezrin-Radixin-Moesin-Binding Phosphoprotein (EBP50), an Estrogen-Inducible Scaffold Protein, Contributes to Biliary Epithelial Cell Proliferation
- (2009) Laura Fouassier et al. AMERICAN JOURNAL OF PATHOLOGY
- Biological role of NHERF1 protein expression in breast cancer
- (2009) Anita Mangia et al. HISTOPATHOLOGY
- Roles of NHERF1/EBP50 in Cancer
- (2008) Maria-Magdalena Georgescu et al. CURRENT MOLECULAR MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now